CoChat

RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

The receptor for advanced glycation end products (RAGE) and its proinflammatory S100/calgranulin ligands are enriched in joints of subjects with rheumatoid arthritis (RA) and amplify the immune/inflammatory response. In a model of inflammatory arthritis, blockade of RAGE in mice immunized and challenged with bovine type II collagen suppressed clinical and histologic evidence of arthritis, in parallel with diminished levels of TNF-alpha, IL-6, and matrix metalloproteinases (MMP) 3, 9 and 13 in affected tissues. Allelic variation within key domains of RAGE may influence these proinflammatory mechanisms, thereby predisposing individuals to heightened inflammatory responses. A polymorphism of the RAGE gene within the ligand-binding domain of the receptor has been identified, consisting of a glycine to serine change at position 82. Cells bearing the RAGE 82S allele displayed enhanced binding and cytokine/MMP generation following ligation by a prototypic S100/calgranulin compared with cells expressing the RAGE 82G allele. In human subjects, a case-control study demonstrated an increased prevalence of the 82S allele in patients with RA compared with control subjects. These data suggest that RAGE 82S upregulates the inflammatory response upon engagement of S100/calgranulins, and, thereby, may contribute to enhanced proinflammatory mechanisms in immune/inflammatory diseases.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.gene.6363861

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 62 references

Cited by

See all 383

Metadata

Authors
Hofmann, M. A., Drury, S., Hudson, B. I., Gleason, M. R., Qu, W., Lu, Y., Lalla, E., Chitnis, S., Monteiro, J., Stickland, M. H., Bucciarelli, L. G., Moser, B., Moxley, G., Itescu, S., Grant, P. J., Gregersen, P. K., Stern, D. M., & Schmidt, A. M.
Affiliations
  • Columbia University (US)
  • University of Leeds (GB)
  • Northwell Health (US)
  • Virginia Commonwealth University (US)
Corresponding author
Schmidt, A M
Venue
Genes & Immunity
Published
2002-05-01
Volume
3
Issue
3
Pages
123-135
ISSN
  • 1466-4879 (ISSN-L)
  • 1476-5470
OpenAlex
W2007281508
Cited by
383
References
61
Citations by year
2025: 10 · 2024: 13 · 2023: 10 · 2022: 8 · 2021: 8 · 2020: 7 · 2019: 8 · 2018: 11 · 2017: 12 · 2016: 27 · 2015: 23 · 2014: 13 · 2013: 14 · 2012: 31
FWCI
11.44
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Genes and Immunity (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › S100 Proteins and Annexins
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Keywords
receptor for advanced glycation end products, RAGE, rheumatoid arthritis, inflammatory arthritis, type II collagen-induced arthritis, TNF-α, interleukin-6, matrix metalloproteinases, ligand-binding domain, genetic susceptibility, cytokine production
MeSH terms
Receptor for Advanced Glycation End Products, Alleles, Animals, Arthritis, Experimental, Arthritis, Rheumatoid, Cricetinae, Humans, Male, Mice, Inbred DBA, Polymorphism, Genetic, Receptors, Immunologic, CHO Cells, Leukocyte L1 Antigen Complex, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. https://app.cochat.ai/papers/10.1038/sj.gene.6363861
The paper
Hofmann, M. A., Drury, S., Hudson, B. I., Gleason, M. R., Qu, W., Lu, Y., Lalla, E., Chitnis, S., Monteiro, J., Stickland, M. H., Bucciarelli, L. G., Moser, B., Moxley, G., Itescu, S., Grant, P. J., Gregersen, P. K., Stern, D. M., & Schmidt, A. M. (2002). RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes & Immunity. https://doi.org/10.1038/sj.gene.6363861

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.